Ellen M Lavoie Smith1, Grace Campbell2, Cindy Tofthagen3, Lisa Kottschade4, Mary L Collins5, Charlene Warton6, Bidisha Ghosh7, David L Ronis7, Gail A Mallory8, Constance Visovsky9. 1. School of Nursing, University of Michigan in Ann Arbor. 2. School of Nursing, University of Pittsburgh in Pennsylvania. 3. College of Nursing, University of South Florida in Tampa. 4. Mayo Clinic, Rochester, MN. 5. Indiana University in Indianapolis. 6. Hudson Valley Hospital Cancer Center, Hudson Valley Hospital, Cortlandt Mannor, NY. 7. School of Nursing, University of Michigan. 8. Oncology Nursing Society in Pittsburgh. 9. College of Nursing, University of South Florida.
Abstract
PURPOSE/ OBJECTIVES: To explore nurses' practice patterns, knowledge, and barriers related to chemotherapy-induced peripheral neuropathy (CIPN). DESIGN: Descriptive, cross-sectional. SETTING: The United States. SAMPLE: 408 oncology nurses. METHODS: A team of eight experts met and developed the CIPN nurse knowledge and preferences survey, which was electronically sent to randomly selected nurses. MAIN RESEARCH VARIABLES: The survey assessed nurses' knowledge and practice patterns regarding assessment strategies and barriers, evidence-based interventions, preferences for education, and perceived gaps in scientific knowledge. FINDINGS: Nurses in the survey lacked knowledge regarding neurotoxicity of specific agents and evidence-based treatments. CIPN-focused physical examinations and standardized measurement tools were infrequently used during assessment. The most frequently reported barriers to CIPN assessment included lack of access to measurement tools, lack of specialized skills needed for assessment, lack of confidence, and lack of time. Recommendations for future research included CIPN prevention research, exploration of CIPN-related effects on quality of life, and alternative treatments of CIPN. The majority of participants preferred online educational opportunities. CONCLUSIONS: Nurses do not consistently integrate evaluation and management of CIPN in their practices. IMPLICATIONS FOR NURSING: Educational offerings should incorporate web-based CIPN assessment and management content.
PURPOSE/ OBJECTIVES: To explore nurses' practice patterns, knowledge, and barriers related to chemotherapy-induced peripheral neuropathy (CIPN). DESIGN: Descriptive, cross-sectional. SETTING: The United States. SAMPLE: 408 oncology nurses. METHODS: A team of eight experts met and developed the CIPN nurse knowledge and preferences survey, which was electronically sent to randomly selected nurses. MAIN RESEARCH VARIABLES: The survey assessed nurses' knowledge and practice patterns regarding assessment strategies and barriers, evidence-based interventions, preferences for education, and perceived gaps in scientific knowledge. FINDINGS: Nurses in the survey lacked knowledge regarding neurotoxicity of specific agents and evidence-based treatments. CIPN-focused physical examinations and standardized measurement tools were infrequently used during assessment. The most frequently reported barriers to CIPN assessment included lack of access to measurement tools, lack of specialized skills needed for assessment, lack of confidence, and lack of time. Recommendations for future research included CIPN prevention research, exploration of CIPN-related effects on quality of life, and alternative treatments of CIPN. The majority of participants preferred online educational opportunities. CONCLUSIONS: Nurses do not consistently integrate evaluation and management of CIPN in their practices. IMPLICATIONS FOR NURSING: Educational offerings should incorporate web-based CIPN assessment and management content.
Authors: Robert Knoerl; Deborah Lee; James Yang; Celia Bridges; Grace Kanzawa-Lee; G Lita Smith; Ellen M Lavoie Smith Journal: J Cancer Educ Date: 2018-10 Impact factor: 2.037
Authors: Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith Journal: Semin Oncol Nurs Date: 2019-04-30 Impact factor: 2.315
Authors: Mary Anne Lagmay Tanay; Glenn Robert; Anne Marie Rafferty; Rona Moss-Morris; Jo Armes Journal: Eur J Cancer Care (Engl) Date: 2021-10-12 Impact factor: 2.328
Authors: Marie Selvy; Bruno Pereira; Nicolas Kerckhove; Jérôme Busserolles; Fadila Farsi; Virginie Guastella; Patrick Merle; Denis Pezet; David Balayssac Journal: Support Care Cancer Date: 2021-01-05 Impact factor: 3.359
Authors: S M Schouten; M E van de Velde; G J L Kaspers; L B Mokkink; I M van der Sluis; C van den Bos; A Hartman; F C H Abbink; M H van den Berg Journal: Support Care Cancer Date: 2019-11-16 Impact factor: 3.603